Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiplatelet therapy in children.

Sara J Israels1, Alan D Michelson

  • 1Department of Pediatrics and Child Health, and the Manitoba Institute of Cell Biology, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0V9. israels@cc.umanitoba.ca

Thrombosis Research
|May 20, 2006
PubMed
Summary

Antiplatelet drugs are widely used in adults but their use in children requires more research. Studies are needed to determine the best antiplatelet strategies for pediatric arterial thrombosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Case Report: Atypical presentations of neonatal and infantile hemophilia B.

Frontiers in pediatrics·2026
Same author

ANKRD26-related thrombocytopenia 2 with a baseline increase in blasts: implications for clinical surveillance.

Blood·2025
Same author

Platelet Pathophysiology: Unexpected New Research Directions.

Seminars in thrombosis and hemostasis·2024
Same author

Corrigendum: Second malignant neoplasms within 5 years from first primary diagnosis in pediatric oncology patients in Canada: a population-based retrospective cohort study.

Frontiers in oncology·2024
Same author

Dysregulation of platelet serotonin, 14-3-3, and GPIX in sudden infant death syndrome.

Scientific reports·2024
Same author

Platelet Physiology.

Seminars in thrombosis and hemostasis·2024

Area of Science:

  • Cardiovascular Medicine
  • Pediatric Thrombosis
  • Pharmacology

Background:

  • Platelets are vital for hemostasis but also contribute to atherosclerosis and arterial thrombosis.
  • Antiplatelet drug use is well-established in adults for preventing thrombotic events.
  • Limited evidence exists for antiplatelet therapy in pediatric populations.

Purpose of the Study:

  • To review the current understanding of antiplatelet drug use in children.
  • To identify knowledge gaps in pediatric arterial thrombosis management.
  • To highlight the need for further research in this area.

Main Methods:

  • Literature review of existing studies on antiplatelet therapy in pediatric populations.
  • Analysis of current guidelines and clinical practices.
  • Identification of specific pediatric conditions requiring antiplatelet therapy.

Main Results:

  • Established protocols for antiplatelet use in adult cardiovascular and cerebrovascular disease prevention.
  • Uncertainty regarding optimal antiplatelet strategies for pediatric ischemic stroke, Kawasaki disease, and post-cardiac surgery thromboembolism.
  • Lack of exploration into newer antiplatelet agents for pediatric arterial thrombosis.

Conclusions:

  • Current antiplatelet strategies in adults are well-defined but not directly applicable to children.
  • Further clinical trials are necessary to establish the efficacy and safety of aspirin and anticoagulants in pediatric thrombosis.
  • The role of novel antiplatelet drugs in pediatric arterial thrombosis remains an unexplored area.

Related Experiment Videos